Pfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata Ruchika Sharma21 Sept 2023 3:30 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for LITFULO (ritlecitinib) to treat...
GSK HIV prevention drug gets European Commission authorisation Ruchika Sharma19 Sept 2023 2:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
Pfizer forecasts 24 percent COVID vaccination rate in US this year Ruchika Sharma19 Sept 2023 10:00 AM ISTNew York: Pfizer expects 24% of the U.S. population, or about 82 million people, to receive COVID-19 shots this year, CFO David Denton said at a...
Pfizer USD 43 billion bid for Seagen to be decided by EU antitrust regulators Ruchika Sharma16 Sept 2023 4:11 PM ISTBrussels: Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on...
Pfizer, BioNTech gets USFDA nod for 2023-2024 COVID vaccine Ruchika Sharma12 Sept 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...
Generate Phase II Clinical Data on 20 Indian subjects for dose selection: CDSCO panel Tells Pfizer on Ritlecitinib Dr. Divya Colin10 Sept 2023 6:00 PM ISTNew Delhi: Noting that in the presented Phase II clinical trial data, no Indian subjects were involved and the study disease is very heterogeneous,...
Pfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease vaccine Ruchika Sharma10 Sept 2023 2:30 PM ISTNew York: Valneva SE and Pfizer Inc. have announced positive pediatric and adolescent immunogenicity and safety data for their Lyme...
Pfizer-BioNTech updated COVID vaccine approved by UK regulator Ruchika Sharma6 Sept 2023 10:00 AM ISTBengaluru: The UK drug regulator said on Tuesday it has approved an updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Pfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID vaccine in EU Ruchika Sharma1 Sept 2023 2:46 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Pfizer expects to restart production at tornado hit plant by early Q4 Ruchika Sharma30 Aug 2023 10:00 AM ISTNorth Carolina: Pfizer said on Monday it expects to restart production at its North Carolina plant by the beginning of the fourth quarter of...
Alnylam plans to appeal ruling on patents related to Moderna COVID vaccine Ruchika Sharma28 Aug 2023 11:30 AM ISTBengaluru: Alnylam Pharmaceuticals has said it plans to appeal a ruling by the U.S. District Court for the District of Delaware on two patents...
